Atlas Trials

Conventionally Fractionated Adaptive Radiation Therapy of Bladder Cancer an Individualized Approach

Clinical trial NCT05295992 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT05295992
Sponsor
Varian, a Siemens Healthineers Company
Status
ACTIVE_NOT_RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Muscle-Invasive Bladder Carcinoma
Start date
2022-03-15
Primary completion
2026-12-01
Enrollment
110

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.